+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Re-evaluation of 129 patients with systemic necrotizing vasculitides by using classification algorithm according to consensus methodology

Re-evaluation of 129 patients with systemic necrotizing vasculitides by using classification algorithm according to consensus methodology

Clinical Rheumatology 31(2): 325-328

Recently, a new classification algorithm (CA) for systemic necrotizing vasculitides was proposed by Watts et al. (Annals Rheum Dis 66:222-227, 2007) by using the American College of Rheumatology (ACR), Chapel Hill Consensus Criteria (CHCC) and Sorensen surrogate markers (So). We aimed to validate CA in our patients. One hundred twenty-nine patients followed up in our vasculitis clinic were reclassified according to CA in different categories (ACR or Lanham criteria in "1" for Churg-Strauss Syndrome (CSS); ACR in "2a"; CHCC-Wegener's granulomatosis (WG) in "2b"; CHCC-microscopic polyangiitis (MPA), So-WG in "2c"; So-WG, proteinase 3 (PR3) or myeloperoxidase antineutrophil cytoplasmic antibody (MPO ANCA) serology in "2d" for WG; clinical features and histology compatible with small vessel vasculitis without So-WG in "3a"; So-MPA, PR3 or MPO ANCA serology in "3b" for MPA; CHCC-classic-polyarteritis nodosa (c-PAN) or typical angiographic features in "4" for c-PAN; unclassifiable in "5"). Kappa statistic was used to analyse the agreement of the criteria that formed the algorithm. All of 12 CSS, 91% of 69 WG, 78% of 18 MPA and 93% of 26 c-PAN patients remained in their previous diagnosis. WG patients were placed in 2a (83%), 2c (3%), 2d (14%) categories. Four WG (6%) and four MPA (22%) patients were categorized as MPA (in 3a (75%), 3b (25%)) and WG (in 2c (75%), 2d (25%)), respectively. Three of four unclassified patients could be classified as c-PAN (two) and MPA (one). Significant agreement was demonstrated only for ACR and So criteria in WG (κ = 0.62, p < 0.001). The majority of our patients stayed on their previous diagnosis in "CA". Our findings suggest that this algorithm is helpful and practical for epidemiological studies. Poor correlation of defined criteria was thought to be related to the fact that each criteria mainly consist of different characteristics of vasculitides such as clinical, histopathological and serological features.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 055376201

Download citation: RISBibTeXText

PMID: 21814755

DOI: 10.1007/s10067-011-1793-3

Related references

Validation of the consensus methodology algorithm for the classification of systemic necrotizing vasculitis in Indian patients. International Journal of Rheumatic Diseases 17(4): 408-411, 2014

Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Annals of the Rheumatic Diseases 66(2): 222-227, 2007

Classification of the systemic vasculitides: antineutrophil cytoplasmic antibodies, consensus and controversy. Clinical and Experimental Rheumatology 16(2): 111-115, 1998

Systemic necrotizing vasculitides in Turkey: a comparative analysis of 40 consecutive patients. Rheumatology International 26(1): 16-20, 2004

Incidence and predictors of urotoxic adverse events in cyclophosphamide-treated patients with systemic necrotizing vasculitides. Arthritis and Rheumatism 63(5): 1435-1445, 2011

Algorithm development for corticosteroid management in systemic juvenile idiopathic arthritis trial using consensus methodology. Pediatric Rheumatology Online Journal 10(1): 31, 2012

Ophthalmologic manifestations of systemic necrotizing vasculitides at diagnosis: a retrospective study of 1286 patients and review of the literature. Seminars in Arthritis and Rheumatism 42(5): 507-514, 2013

Factors associated with major cardiovascular events in patients with systemic necrotizing vasculitides: results of a longterm followup study. Journal of Rheumatology 41(4): 723-729, 2014

Periostitis in systemic necrotizing vasculitides: Study of the 4 cases identified among the 1762 patients of the FVSG database and review of the literature. Presse Medicale 39(7-8): E165-E173, 2010

Classification of the necrotizing vasculitides in man. Clinics in Rheumatic Diseases 6(2): 223-232, 1980

Classification of the necrotizing vasculitides. Australian & New Zealand Journal of Medicine 11(3): 336, 1981

The necrotizing vasculitides. A new pathogenetic classification. Medical Clinics of North America 61(2): 241-260, 1977

Immunosuppressants in systemic necrotizing vasculitides. Israel Medical Association Journal 3(10): 749-754, 2001

How to treat systemic necrotizing vasculitides?. Presse Medicale 41(10): 1024-1030, 2012

Histopathological differentiation of systemic necrotizing vasculitides. Apmis. Supplementum 19: 17-18, 1990